A weight management service for Nigerians that takes the medicine seriously, treats patients like adults, and doesn't cut corners on cold chain.
Tirzepatide has shown strong weight-loss outcomes in published GLP-1 clinical trials, but trustworthy access in Nigeria is difficult. The people looking for medical weight support are often left with diets that don't work and supplements that do nothing.
Even when people sourced GLP-1 medications privately, they arrived warm. Tirzepatide degrades outside 2–8°C. A warm pen is an expensive placebo. Nobody was solving the last-mile cold chain problem for Nigerian consumers.
People were self-prescribing doses, skipping the manufacturer's titration ladder, and dealing with severe nausea because nobody told them to start at 2.5mg. The medication works, but only if you use it correctly.
We built the service that solves all three: branded Tirzepatide from a verified manufacturer, delivered cold to your door, with a care team that reviews your health before your first dose and supports you through treatment.
Second Cure is a treatment service built by people who were frustrated by the gap between what GLP-1 medications can do and how they're actually accessed in Nigeria. We're not a pharmacy. We're not a hospital. We're the infrastructure that connects you to effective treatment safely.
Tirzepatide must stay between 2–8°C. We refrigerate from the moment stock arrives at our facility through to your doorstep. If a package goes warm, we don't send it. Full stop.
We supply Tizaro (Tirzepatide) by Ziska Pharmaceuticals — a branded, batch-verified product. No compounded copies, no grey-market alternatives, no cutting corners on the thing that goes into your body.
Everyone starts at 2.5mg. Not because we're being cautious for the sake of it, but because the manufacturer's dose ladder exists for a reason: it reduces nausea and lets your body adjust before increasing the effect.
We review your health before approving treatment, we deliver medication safely, and we support you through the process. If something in your assessment concerns us, we'll tell you directly rather than approve an order we shouldn't.
Second Cure is operated by Second Cure Labs Ltd from within Nigeria. We source, store, review, and deliver domestically — not from a warehouse in Europe hoping it arrives cold. We currently serve Abuja, with Lagos and other Nigerian states launching later this year.
We started this because we wanted access to Tirzepatide ourselves and couldn't find a trustworthy way to get it in Nigeria. Every decision we make comes from that frustration.
We sell one medication: Tirzepatide. We don't try to be a general pharmacy or a wellness brand. We do one thing — GLP-1 treatment — and we do it properly: cold chain, batch verified, care team reviewed.
People in Nigeria are already buying GLP-1 medications through informal channels. Here's why that's risky and what we do differently.
“Care team” is deliberate language. Here’s what it actually means.
Every assessment is read by a person trained in tirzepatide screening protocols: eligibility, contraindications, drug interactions, BMI thresholds, and dose appropriateness. They don’t rush and they don’t rubber-stamp. Reviews take up to 24 hours for a reason.
Borderline cases — unusual medical history, medications that could interact, red flags in the screening — are escalated to a senior reviewer using documented screening protocols and source references. If we can’t clear a case confidently, we refuse. Refusing a sale is built into the workflow.
We keep our scope narrow, and we don’t pretend otherwise. If your case needs diagnosis, a prescription outside our stocked programme, or ongoing medical management beyond tirzepatide support, we tell you and refund. Scope honesty is how you stay safe at a distance.
Based in Nigeria, currently serving Abuja. Support hours 10am–4pm WAT, Monday to Friday, over WhatsApp and email. Urgent medical symptoms always mean: call 112, then message us. We built an escalation flow that tells you exactly that, in the moment you need it.
We think you deserve to know exactly what you're signing up for. Here's the honest version.
We source Tirzepatide, review your health information, deliver the medication cold, and support you through treatment. That's our scope and we're good at it.
If your assessment reveals something that needs in-person medical attention, we'll tell you. We won't approve an order just to make a sale.
Published tirzepatide studies show meaningful average weight loss, but individual results vary. It works best alongside smaller meals, regular movement, and realistic expectations. We'll be honest about that.
This isn't a UK or US service repackaged for Africa. We're Nigerian-operated — we understand the food, the lifestyle, and the culture. Our learn articles cover jollof, pounded yam, and chin chin — not kale smoothies.
Nigeria has one of the fastest-growing obesity rates in Sub-Saharan Africa. The conversation about weight is changing — from "big is beautiful" to recognising the health risks of carrying excess weight: diabetes, hypertension, joint pain, sleep apnoea. But the solutions available haven't kept up.
Tirzepatide (a dual GIP/GLP-1 receptor agonist) showed 22.5% average body weight reduction in the SURMOUNT-1 trial. It is available in the US, UK, Europe, and parts of Asia, but Nigerian access has often depended on informal sourcing with weak cold-chain and little screening.
We exist to close that gap. Not by being the cheapest option — ₦275,000 is a serious investment — but by focusing on the things we can control: review, authenticity checks, cold-chain handling, and support.
Complete your health questionnaire in 3–5 minutes. Your care team will review it within 24 hours and confirm whether treatment is right for you.